358 related articles for article (PubMed ID: 25735801)
1. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
4. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
[TBL] [Abstract][Full Text] [Related]
5. Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles.
Wang X; Yang C; Zhang Y; Zhen X; Wu W; Jiang X
Biomaterials; 2014 Aug; 35(24):6439-53. PubMed ID: 24811257
[TBL] [Abstract][Full Text] [Related]
6. LHRH-peptide conjugated dextran nanoparticles for targeted delivery of cisplatin to breast cancer.
Li M; Tang Z; Zhang Y; Lv S; Yu H; Zhang D; Hong H; Chen X
J Mater Chem B; 2014 Jun; 2(22):3490-3499. PubMed ID: 32261469
[TBL] [Abstract][Full Text] [Related]
7. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
Engel J; Emons G; Pinski J; Schally AV
Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity.
Xu Y; Han X; Li Y; Min H; Zhao X; Zhang Y; Qi Y; Shi J; Qi S; Bao Y; Nie G
ACS Nano; 2019 Nov; 13(11):13445-13455. PubMed ID: 31670945
[TBL] [Abstract][Full Text] [Related]
9. LHRH Targeted Chonderosomes of Mitomycin C in Breast Cancer: An
Varshosaz J; Sarrami N; Aghaei M; Aliomrani M; Azizi R
Anticancer Agents Med Chem; 2019; 19(11):1405-1417. PubMed ID: 30987576
[TBL] [Abstract][Full Text] [Related]
10. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin.
Song W; Tang Z; Zhang D; Zhang Y; Yu H; Li M; Lv S; Sun H; Deng M; Chen X
Biomaterials; 2014 Mar; 35(9):3005-14. PubMed ID: 24388813
[TBL] [Abstract][Full Text] [Related]
12. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.
Leuschner C; Kumar CS; Hansel W; Soboyejo W; Zhou J; Hormes J
Breast Cancer Res Treat; 2006 Sep; 99(2):163-76. PubMed ID: 16752077
[TBL] [Abstract][Full Text] [Related]
13. Tumor accumulation, penetration, and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticles.
Ding D; Wang J; Zhu Z; Li R; Wu W; Liu B; Jiang X
ACS Appl Mater Interfaces; 2012 Mar; 4(3):1838-46. PubMed ID: 22364315
[TBL] [Abstract][Full Text] [Related]
14. The effect of lipocisplatin on cisplatin efficacy and nephrotoxicity in malignant breast cancer treatment.
Li Q; Tian Y; Li D; Sun J; Shi D; Fang L; Gao Y; Liu H
Biomaterials; 2014 Aug; 35(24):6462-72. PubMed ID: 24797881
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.
Wang Y; Liu P; Qiu L; Sun Y; Zhu M; Gu L; Di W; Duan Y
Biomaterials; 2013 May; 34(16):4068-4077. PubMed ID: 23480957
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
Tan S; Wang G
Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
[TBL] [Abstract][Full Text] [Related]
17. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
18. Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer.
Xu G; Chen Y; Shan R; Wu X; Chen L
Biomed Pharmacother; 2018 Mar; 99():354-362. PubMed ID: 29358128
[TBL] [Abstract][Full Text] [Related]
19. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
